David A. Siegel Genetron Holdings LTD Transaction History

Two Sigma Advisers, LP

  • $43.8 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.28 - $2.4 $41,728 - $78,240
-32,600 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$2.19 - $6.09 $92,418 - $256,998
-42,200 Reduced 56.42%
32,600 $71,000
Q4 2021

Feb 14, 2022
BUY
$5.81 - $14.39 $434,587 - $1.08 Million
74,800 New
74,800 $456,000
Q4 2020

Feb 16, 2021
SELL
$9.31 - $14.0 $136,857 - $205,800
-14,700 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$9.1 - $15.81 $133,770 - $232,407
14,700 New
14,700 $176,000

Others Institutions Holding GTH

# of Institutions
1
Shares Held
7.5K
Call Options Held
0
Put Options Held
0
View Full List

About Genetron Holdings Ltd

GTH Quotes by TradingView
  • Ticker GTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 90,602,304
  • Description
  • Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...
More about GTH
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email